IBDEI163 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20874,1,8,0)
 ;;=8^Chr Leukemia w/o Remission
 ;;^UTILITY(U,$J,358.3,20874,2)
 ;;=^336871
 ;;^UTILITY(U,$J,358.3,20875,0)
 ;;=208.11^^118^1255^11
 ;;^UTILITY(U,$J,358.3,20875,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20875,1,1,0)
 ;;=1^208.11
 ;;^UTILITY(U,$J,358.3,20875,1,8,0)
 ;;=8^Chr Leukemia in Remission
 ;;^UTILITY(U,$J,358.3,20875,2)
 ;;=^267569
 ;;^UTILITY(U,$J,358.3,20876,0)
 ;;=208.12^^118^1255^10
 ;;^UTILITY(U,$J,358.3,20876,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20876,1,1,0)
 ;;=1^208.12
 ;;^UTILITY(U,$J,358.3,20876,1,8,0)
 ;;=8^Chr Leukemia in Relapse
 ;;^UTILITY(U,$J,358.3,20876,2)
 ;;=^336486
 ;;^UTILITY(U,$J,358.3,20877,0)
 ;;=208.20^^118^1255^53
 ;;^UTILITY(U,$J,358.3,20877,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20877,1,1,0)
 ;;=1^208.20
 ;;^UTILITY(U,$J,358.3,20877,1,8,0)
 ;;=8^Subacute Leukemia w/o Remission
 ;;^UTILITY(U,$J,358.3,20877,2)
 ;;=^336872
 ;;^UTILITY(U,$J,358.3,20878,0)
 ;;=208.21^^118^1255^52
 ;;^UTILITY(U,$J,358.3,20878,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20878,1,1,0)
 ;;=1^208.21
 ;;^UTILITY(U,$J,358.3,20878,1,8,0)
 ;;=8^Subacute Leukemia in Remission
 ;;^UTILITY(U,$J,358.3,20878,2)
 ;;=^267572
 ;;^UTILITY(U,$J,358.3,20879,0)
 ;;=208.22^^118^1255^51
 ;;^UTILITY(U,$J,358.3,20879,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20879,1,1,0)
 ;;=1^208.22
 ;;^UTILITY(U,$J,358.3,20879,1,8,0)
 ;;=8^Subacute Leukemia in Relapse
 ;;^UTILITY(U,$J,358.3,20879,2)
 ;;=^336487
 ;;^UTILITY(U,$J,358.3,20880,0)
 ;;=208.80^^118^1255^38
 ;;^UTILITY(U,$J,358.3,20880,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20880,1,1,0)
 ;;=1^208.80
 ;;^UTILITY(U,$J,358.3,20880,1,8,0)
 ;;=8^Oth Leuk Unspec Cell Type w/o Rem
 ;;^UTILITY(U,$J,358.3,20880,2)
 ;;=^336873
 ;;^UTILITY(U,$J,358.3,20881,0)
 ;;=208.81^^118^1255^37
 ;;^UTILITY(U,$J,358.3,20881,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20881,1,1,0)
 ;;=1^208.81
 ;;^UTILITY(U,$J,358.3,20881,1,8,0)
 ;;=8^Oth Leuk Unspec Cell Type w/ Rem
 ;;^UTILITY(U,$J,358.3,20881,2)
 ;;=^267574
 ;;^UTILITY(U,$J,358.3,20882,0)
 ;;=208.82^^118^1255^36
 ;;^UTILITY(U,$J,358.3,20882,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20882,1,1,0)
 ;;=1^208.82
 ;;^UTILITY(U,$J,358.3,20882,1,8,0)
 ;;=8^Oth Leuk Unspec Cell Type in Relap
 ;;^UTILITY(U,$J,358.3,20882,2)
 ;;=^336488
 ;;^UTILITY(U,$J,358.3,20883,0)
 ;;=209.00^^118^1255^25
 ;;^UTILITY(U,$J,358.3,20883,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20883,1,1,0)
 ;;=1^209.00
 ;;^UTILITY(U,$J,358.3,20883,1,8,0)
 ;;=8^Mal Carcinoid Tumor,Sm Intestine
 ;;^UTILITY(U,$J,358.3,20883,2)
 ;;=^336721
 ;;^UTILITY(U,$J,358.3,20884,0)
 ;;=209.01^^118^1255^22
 ;;^UTILITY(U,$J,358.3,20884,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20884,1,1,0)
 ;;=1^209.01
 ;;^UTILITY(U,$J,358.3,20884,1,8,0)
 ;;=8^Mal Carcinoid Tumor,Duodenum
 ;;^UTILITY(U,$J,358.3,20884,2)
 ;;=^336490
 ;;^UTILITY(U,$J,358.3,20885,0)
 ;;=209.02^^118^1255^24
 ;;^UTILITY(U,$J,358.3,20885,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20885,1,1,0)
 ;;=1^209.02
 ;;^UTILITY(U,$J,358.3,20885,1,8,0)
 ;;=8^Mal Carcinoid Tumor,Jejunum
 ;;^UTILITY(U,$J,358.3,20885,2)
 ;;=^336491
 ;;^UTILITY(U,$J,358.3,20886,0)
 ;;=209.03^^118^1255^23
 ;;^UTILITY(U,$J,358.3,20886,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20886,1,1,0)
 ;;=1^209.03
 ;;^UTILITY(U,$J,358.3,20886,1,8,0)
 ;;=8^Mal Carcinoid Tumor,Ileum
 ;;^UTILITY(U,$J,358.3,20886,2)
 ;;=^336492
 ;;^UTILITY(U,$J,358.3,20887,0)
 ;;=204.00^^118^1256^1
 ;;^UTILITY(U,$J,358.3,20887,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20887,1,1,0)
 ;;=1^204.00
 ;;^UTILITY(U,$J,358.3,20887,1,8,0)
 ;;=8^ALL w/o Remission
